Page last updated: 2024-08-21

lithium carbonate and Cerebral Ischemia

lithium carbonate has been researched along with Cerebral Ischemia in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Mayer, G	1
Eblen-Zajjur, A; Wix-Ramos, R	1
Blume, A; Brecht, S; Culman, J; Gohlke, P; Xu, J	1

Reviews

1 review(s) available for lithium carbonate and Cerebral Ischemia

Article	Year
[The Kleine-Levin syndrome: new aspects of a rare disease]. Der Nervenarzt, 2013, Volume: 84, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alleles; Brain; Brain Ischemia; Central Nervous System Stimulants; Child; Child, Preschool; Cross-Sectional Studies; Diagnosis, Differential; Dominance, Cerebral; Female; HLA-DQ beta-Chains; Humans; Intracellular Signaling Peptides and Proteins; Kleine-Levin Syndrome; Lithium Carbonate; Male; Middle Aged; Neuropeptides; Orexins; Phenotype; Prognosis; Rare Diseases; Sleep Stages; Thalamus; Young Adult	2013

Article

Year

[The Kleine-Levin syndrome: new aspects of a rare disease].

Der Nervenarzt, 2013, Volume: 84, Issue:10

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alleles; Brain; Brain Ischemia; Central Nervous System Stimulants; Child; Child, Preschool; Cross-Sectional Studies; Diagnosis, Differential; Dominance, Cerebral; Female; HLA-DQ beta-Chains; Humans; Intracellular Signaling Peptides and Proteins; Kleine-Levin Syndrome; Lithium Carbonate; Male; Middle Aged; Neuropeptides; Orexins; Phenotype; Prognosis; Rare Diseases; Sleep Stages; Thalamus; Young Adult

2013

Other Studies

2 other study(ies) available for lithium carbonate and Cerebral Ischemia

Article	Year
Time course of acute neuroprotective effects of lithium carbonate evaluated by brain impedanciometry in the global ischemia model. Canadian journal of physiology and pharmacology, 2011, Volume: 89, Issue:10 Topics: Animals; Brain; Brain Ischemia; Disease Models, Animal; Dose-Response Relationship, Drug; Electric Impedance; Humans; Infusions, Intravenous; Lithium Carbonate; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Time Factors	2011
Chronic treatment with a low dose of lithium protects the brain against ischemic injury by reducing apoptotic death. Stroke, 2003, Volume: 34, Issue:5 Topics: Animals; Apoptosis; Biomarkers; Brain Edema; Brain Ischemia; Caspase 3; Caspases; Cerebrovascular Circulation; Depression, Chemical; Drug Administration Schedule; Drug Evaluation, Preclinical; In Situ Nick-End Labeling; Infarction, Middle Cerebral Artery; Lithium Carbonate; Male; Microglia; Nerve Tissue Proteins; Neuroprotective Agents; Rats; Rats, Wistar; Reperfusion Injury; Single-Blind Method; Transcription Factor AP-1	2003

Article

Year

Time course of acute neuroprotective effects of lithium carbonate evaluated by brain impedanciometry in the global ischemia model.

Canadian journal of physiology and pharmacology, 2011, Volume: 89, Issue:10

Topics: Animals; Brain; Brain Ischemia; Disease Models, Animal; Dose-Response Relationship, Drug; Electric Impedance; Humans; Infusions, Intravenous; Lithium Carbonate; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Time Factors

2011

Chronic treatment with a low dose of lithium protects the brain against ischemic injury by reducing apoptotic death.

Stroke, 2003, Volume: 34, Issue:5

Topics: Animals; Apoptosis; Biomarkers; Brain Edema; Brain Ischemia; Caspase 3; Caspases; Cerebrovascular Circulation; Depression, Chemical; Drug Administration Schedule; Drug Evaluation, Preclinical; In Situ Nick-End Labeling; Infarction, Middle Cerebral Artery; Lithium Carbonate; Male; Microglia; Nerve Tissue Proteins; Neuroprotective Agents; Rats; Rats, Wistar; Reperfusion Injury; Single-Blind Method; Transcription Factor AP-1

2003